104 filings
8-K
INTS
Intensity Therapeutics Inc
15 May 24
Intensity Therapeutics, Inc. Announces the Appointment of Thomas Dubin to Its Board of Directors
4:25pm
8-K
INTS
Intensity Therapeutics Inc
10 May 24
Entry into a Material Definitive Agreement
4:00pm
8-K
INTS
Intensity Therapeutics Inc
9 May 24
Intensity Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
4:13pm
10-Q
2024 Q1
INTS
Intensity Therapeutics Inc
Quarterly report
9 May 24
4:01pm
8-K
INTS
Intensity Therapeutics Inc
19 Apr 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:01pm
8-K
73wqe3utzjlzg3
14 Mar 24
Intensity Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
4:12pm
10-K
lfg6jhm
14 Mar 24
Annual report
4:01pm
8-K
lgtyhfb3n1410gi3uv
7 Feb 24
Departure of Directors or Certain Officers
4:15pm
8-K
17499
12 Dec 23
Intensity Therapeutics Appoints Joseph Talamo, CPA, as Chief Financial Officer
8:02am
8-K
tcsu7rs1 uqqcq
22 Nov 23
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
7qsfh3yv7tjmcgeons5
13 Nov 23
Intensity Therapeutics Reports Third Quarter Financial Results and Provides Corporate Update
8:02am
8-K
63uv96q8bkj0awfk3 uv
5 Sep 23
Intensity Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference
8:05am
S-8
hv6fjci grz
22 Aug 23
Registration of securities for employees
3:37pm
10-Q
6mzo37vht
14 Aug 23
Quarterly report
12:45pm
8-K
j07z ftq4
14 Aug 23
Intensity Therapeutics Reports Second Quarter Financial Results and Provides Corporate Update
7:00am
8-K
2mv rc66wvaf
10 Jul 23
Other Events
8:30am
8-K
vt43heg cccm9kmf
5 Jul 23
Intensity Therapeutics, Inc. Announces Pricing of Upsized Initial Public Offering, Raising Approximately $19.5 Million in Gross Proceeds
4:47pm
424B4
0pe 3y6rjf
30 Jun 23
Prospectus supplement with pricing info
3:49pm